vs
Acadia Healthcare Company, Inc.（ACHC）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
罗布乐思的季度营收约是Acadia Healthcare Company, Inc.的1.7倍（$1.4B vs $829.0M），Acadia Healthcare Company, Inc.净利率更高（0.5% vs -22.3%，领先22.9%），罗布乐思同比增速更快（43.2% vs 7.5%），过去两年罗布乐思的营收复合增速更高（32.9% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
ACHC vs RBLX — 直观对比
营收规模更大
RBLX
是对方的1.7倍
$829.0M
营收增速更快
RBLX
高出35.7%
7.5%
净利率更高
ACHC
高出22.9%
-22.3%
两年增速更快
RBLX
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.4B |
| 净利润 | $4.5M | $-316.0M |
| 毛利率 | — | 77.7% |
| 营业利润率 | — | -25.3% |
| 净利率 | 0.5% | -22.3% |
| 营收同比 | 7.5% | 43.2% |
| 净利润同比 | -50.8% | -43.9% |
| 每股收益（稀释后） | $0.05 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCRBLX
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.4B | ||
| Q3 25 | $851.6M | $1.4B | ||
| Q2 25 | $869.2M | $1.1B | ||
| Q1 25 | $770.5M | $1.0B | ||
| Q4 24 | $774.2M | $988.2M | ||
| Q3 24 | $815.6M | $919.0M | ||
| Q2 24 | $796.0M | $893.5M |
净利润ACHCRBLX
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-316.0M | ||
| Q3 25 | $36.2M | $-255.6M | ||
| Q2 25 | $30.1M | $-278.4M | ||
| Q1 25 | $8.4M | $-215.1M | ||
| Q4 24 | $32.6M | $-219.6M | ||
| Q3 24 | $68.1M | $-239.3M | ||
| Q2 24 | $78.5M | $-205.9M |
毛利率ACHCRBLX
| Q1 26 | — | — | ||
| Q4 25 | — | 77.7% | ||
| Q3 25 | — | 78.2% | ||
| Q2 25 | — | 78.2% | ||
| Q1 25 | — | 78.3% | ||
| Q4 24 | — | 77.9% | ||
| Q3 24 | — | 77.7% | ||
| Q2 24 | — | 77.8% |
营业利润率ACHCRBLX
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -25.3% | ||
| Q3 25 | 4.7% | -21.8% | ||
| Q2 25 | 5.8% | -29.8% | ||
| Q1 25 | 1.7% | -24.6% | ||
| Q4 24 | 4.9% | -24.7% | ||
| Q3 24 | 12.1% | -30.4% | ||
| Q2 24 | 13.4% | -26.6% |
净利率ACHCRBLX
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -22.3% | ||
| Q3 25 | 4.3% | -18.8% | ||
| Q2 25 | 3.5% | -25.8% | ||
| Q1 25 | 1.1% | -20.8% | ||
| Q4 24 | 4.2% | -22.2% | ||
| Q3 24 | 8.4% | -26.0% | ||
| Q2 24 | 9.9% | -23.0% |
每股收益（稀释后）ACHCRBLX
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $-0.44 | ||
| Q3 25 | $0.40 | $-0.37 | ||
| Q2 25 | $0.33 | $-0.41 | ||
| Q1 25 | $0.09 | $-0.32 | ||
| Q4 24 | $0.36 | $-0.32 | ||
| Q3 24 | $0.74 | $-0.37 | ||
| Q2 24 | $0.85 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $3.1B |
| 总债务越低越好 | $2.5B | $1.2B |
| 股东权益账面价值 | $2.0B | $394.5M |
| 总资产 | $5.5B | $9.6B |
| 负债/权益比越低杠杆越低 | 1.29× | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资ACHCRBLX
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $3.1B | ||
| Q3 25 | $118.7M | $2.9B | ||
| Q2 25 | $131.4M | $2.6B | ||
| Q1 25 | $91.2M | $2.7B | ||
| Q4 24 | $76.3M | $2.4B | ||
| Q3 24 | $82.1M | $2.3B | ||
| Q2 24 | $77.2M | $2.4B |
总债务ACHCRBLX
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCRBLX
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $394.5M | ||
| Q3 25 | $3.1B | $407.6M | ||
| Q2 25 | $3.1B | $353.2M | ||
| Q1 25 | $3.0B | $310.7M | ||
| Q4 24 | $3.1B | $221.4M | ||
| Q3 24 | $3.0B | $189.9M | ||
| Q2 24 | $3.0B | $121.5M |
总资产ACHCRBLX
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $9.6B | ||
| Q3 25 | $6.4B | $8.6B | ||
| Q2 25 | $6.3B | $7.8B | ||
| Q1 25 | $6.1B | $7.5B | ||
| Q4 24 | $6.0B | $7.2B | ||
| Q3 24 | $5.9B | $6.7B | ||
| Q2 24 | $5.7B | $6.5B |
负债/权益比ACHCRBLX
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 2.98× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 5.48× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $607.0M |
| 自由现金流经营现金流 - 资本支出 | — | $308.6M |
| 自由现金流率自由现金流/营收 | — | 21.8% |
| 资本支出强度资本支出/营收 | — | 21.1% |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | $1.4B |
8季度趋势，按日历期对齐
经营现金流ACHCRBLX
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $607.0M | ||
| Q3 25 | $73.2M | $546.2M | ||
| Q2 25 | $133.5M | $199.3M | ||
| Q1 25 | $11.5M | $443.9M | ||
| Q4 24 | $116.7M | $184.5M | ||
| Q3 24 | $163.1M | $247.4M | ||
| Q2 24 | $171.1M | $151.4M |
自由现金流ACHCRBLX
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $308.6M | ||
| Q3 25 | $-63.0M | $443.6M | ||
| Q2 25 | $-34.2M | $176.7M | ||
| Q1 25 | $-163.2M | $426.5M | ||
| Q4 24 | $-86.8M | $120.6M | ||
| Q3 24 | $-27.1M | $218.0M | ||
| Q2 24 | $16.9M | $111.7M |
自由现金流率ACHCRBLX
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 21.8% | ||
| Q3 25 | -7.4% | 32.6% | ||
| Q2 25 | -3.9% | 16.3% | ||
| Q1 25 | -21.2% | 41.2% | ||
| Q4 24 | -11.2% | 12.2% | ||
| Q3 24 | -3.3% | 23.7% | ||
| Q2 24 | 2.1% | 12.5% |
资本支出强度ACHCRBLX
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 21.1% | ||
| Q3 25 | 16.0% | 7.5% | ||
| Q2 25 | 19.3% | 2.1% | ||
| Q1 25 | 22.7% | 1.7% | ||
| Q4 24 | 26.3% | 6.5% | ||
| Q3 24 | 23.3% | 3.2% | ||
| Q2 24 | 19.4% | 4.4% |
现金转化率ACHCRBLX
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
RBLX
暂无分部数据
